vs
J&J SNACK FOODS CORP（JJSF）与Prestige Consumer Healthcare Inc.（PBH）财务数据对比。点击上方公司名可切换其他公司
J&J SNACK FOODS CORP的季度营收约是Prestige Consumer Healthcare Inc.的1.2倍（$343.8M vs $283.4M），Prestige Consumer Healthcare Inc.净利率更高（16.5% vs 0.3%，领先16.2%），Prestige Consumer Healthcare Inc.同比增速更快（-2.4% vs -5.2%），Prestige Consumer Healthcare Inc.自由现金流更多（$75.3M vs $17.0M），过去两年Prestige Consumer Healthcare Inc.的营收复合增速更高（1.2% vs -2.2%）
强生休闲食品公司（J&J Snack Foods Corp.）是美国知名的品牌休闲食品与冷冻饮品生产商、营销商及分销商，总部位于新泽西州芒特劳雷尔，在全美44个州、墨西哥及加拿大设有超175个生产、仓储及配送设施，于纳斯达克全球精选市场上市，业务覆盖国内外市场。
Prestige Consumer Healthcare Inc.是一家美国企业，主营非处方健康护理产品及家用清洁产品的营销与分销业务。该公司于1996年由Medtech Products、Prestige Brands International及Spic and Span三家公司合并成立，总部位于纽约州塔里敦，在弗吉尼亚州林奇堡设有生产工厂。
JJSF vs PBH — 直观对比
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $343.8M | $283.4M |
| 净利润 | $883.0K | $46.7M |
| 毛利率 | 27.9% | 55.5% |
| 营业利润率 | 0.2% | 29.1% |
| 净利率 | 0.3% | 16.5% |
| 营收同比 | -5.2% | -2.4% |
| 净利润同比 | -82.8% | -23.5% |
| 每股收益（稀释后） | $0.05 | $0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $343.8M | $283.4M | ||
| Q3 25 | $410.2M | $274.1M | ||
| Q2 25 | $454.3M | $249.5M | ||
| Q1 25 | $356.1M | $296.5M | ||
| Q4 24 | $362.6M | $290.3M | ||
| Q3 24 | $426.8M | $283.8M | ||
| Q2 24 | $440.0M | $267.1M | ||
| Q1 24 | $359.7M | $277.0M |
| Q4 25 | $883.0K | $46.7M | ||
| Q3 25 | $11.4M | $42.2M | ||
| Q2 25 | $44.2M | $47.5M | ||
| Q1 25 | $4.8M | $50.1M | ||
| Q4 24 | $5.1M | $61.0M | ||
| Q3 24 | $29.6M | $54.4M | ||
| Q2 24 | $36.3M | $49.1M | ||
| Q1 24 | $13.3M | $49.5M |
| Q4 25 | 27.9% | 55.5% | ||
| Q3 25 | 31.7% | 55.3% | ||
| Q2 25 | 33.0% | 56.2% | ||
| Q1 25 | 26.9% | 57.3% | ||
| Q4 24 | 25.9% | 55.5% | ||
| Q3 24 | 31.8% | 55.5% | ||
| Q2 24 | 33.6% | 54.7% | ||
| Q1 24 | 30.1% | 54.8% |
| Q4 25 | 0.2% | 29.1% | ||
| Q3 25 | 2.8% | 29.1% | ||
| Q2 25 | 13.3% | 28.8% | ||
| Q1 25 | 1.7% | 29.8% | ||
| Q4 24 | 1.7% | 31.7% | ||
| Q3 24 | 9.3% | 29.7% | ||
| Q2 24 | 11.4% | 27.0% | ||
| Q1 24 | 5.0% | 29.7% |
| Q4 25 | 0.3% | 16.5% | ||
| Q3 25 | 2.8% | 15.4% | ||
| Q2 25 | 9.7% | 19.0% | ||
| Q1 25 | 1.4% | 16.9% | ||
| Q4 24 | 1.4% | 21.0% | ||
| Q3 24 | 6.9% | 19.2% | ||
| Q2 24 | 8.3% | 18.4% | ||
| Q1 24 | 3.7% | 17.9% |
| Q4 25 | $0.05 | $0.97 | ||
| Q3 25 | $0.59 | $0.86 | ||
| Q2 25 | $2.26 | $0.95 | ||
| Q1 25 | $0.25 | $1.00 | ||
| Q4 24 | $0.26 | $1.22 | ||
| Q3 24 | $1.52 | $1.09 | ||
| Q2 24 | $1.87 | $0.98 | ||
| Q1 24 | $0.69 | $0.98 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $66.8M | $62.4M |
| 总债务越低越好 | — | $1.0B |
| 股东权益账面价值 | $912.9M | $1.8B |
| 总资产 | $1.3B | $3.5B |
| 负债/权益比越低杠杆越低 | — | 0.56× |
8季度趋势，按日历期对齐
| Q4 25 | $66.8M | $62.4M | ||
| Q3 25 | $105.9M | $119.1M | ||
| Q2 25 | $77.4M | $139.5M | ||
| Q1 25 | $48.5M | $97.9M | ||
| Q4 24 | $73.6M | $50.9M | ||
| Q3 24 | $73.4M | $51.5M | ||
| Q2 24 | $64.0M | $34.3M | ||
| Q1 24 | $43.6M | $46.5M |
| Q4 25 | — | $1.0B | ||
| Q3 25 | — | $993.1M | ||
| Q2 25 | — | $992.7M | ||
| Q1 25 | — | $992.4M | ||
| Q4 24 | — | $992.0M | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $1.1B |
| Q4 25 | $912.9M | $1.8B | ||
| Q3 25 | $966.7M | $1.8B | ||
| Q2 25 | $969.9M | $1.9B | ||
| Q1 25 | $935.0M | $1.8B | ||
| Q4 24 | $946.8M | $1.8B | ||
| Q3 24 | $957.0M | $1.7B | ||
| Q2 24 | $937.9M | $1.7B | ||
| Q1 24 | $915.7M | $1.7B |
| Q4 25 | $1.3B | $3.5B | ||
| Q3 25 | $1.4B | $3.4B | ||
| Q2 25 | $1.4B | $3.4B | ||
| Q1 25 | $1.4B | $3.4B | ||
| Q4 24 | $1.3B | $3.3B | ||
| Q3 24 | $1.4B | $3.3B | ||
| Q2 24 | $1.4B | $3.3B | ||
| Q1 24 | $1.3B | $3.3B |
| Q4 25 | — | 0.56× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.54× | ||
| Q4 24 | — | 0.55× | ||
| Q3 24 | — | 0.61× | ||
| Q2 24 | — | 0.65× | ||
| Q1 24 | — | 0.68× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $36.0M | $78.3M |
| 自由现金流经营现金流 - 资本支出 | $17.0M | $75.3M |
| 自由现金流率自由现金流/营收 | 4.9% | 26.6% |
| 资本支出强度资本支出/营收 | 5.5% | 1.1% |
| 现金转化率经营现金流/净利润 | 40.73× | 1.68× |
| 过去12个月自由现金流最近4个季度 | $83.1M | $267.2M |
8季度趋势，按日历期对齐
| Q4 25 | $36.0M | $78.3M | ||
| Q3 25 | $66.4M | $57.5M | ||
| Q2 25 | $51.2M | $79.0M | ||
| Q1 25 | $12.3M | $61.8M | ||
| Q4 24 | $35.2M | $65.1M | ||
| Q3 24 | $46.3M | $69.8M | ||
| Q2 24 | $65.0M | $54.8M | ||
| Q1 24 | $12.7M | $66.9M |
| Q4 25 | $17.0M | $75.3M | ||
| Q3 25 | $44.8M | $55.4M | ||
| Q2 25 | $28.5M | $78.2M | ||
| Q1 25 | $-7.2M | $58.4M | ||
| Q4 24 | $16.1M | $63.5M | ||
| Q3 24 | $29.1M | $67.8M | ||
| Q2 24 | $45.3M | $53.6M | ||
| Q1 24 | $-4.0M | $63.8M |
| Q4 25 | 4.9% | 26.6% | ||
| Q3 25 | 10.9% | 20.2% | ||
| Q2 25 | 6.3% | 31.3% | ||
| Q1 25 | -2.0% | 19.7% | ||
| Q4 24 | 4.4% | 21.9% | ||
| Q3 24 | 6.8% | 23.9% | ||
| Q2 24 | 10.3% | 20.1% | ||
| Q1 24 | -1.1% | 23.0% |
| Q4 25 | 5.5% | 1.1% | ||
| Q3 25 | 5.3% | 0.8% | ||
| Q2 25 | 5.0% | 0.3% | ||
| Q1 25 | 5.5% | 1.2% | ||
| Q4 24 | 5.3% | 0.5% | ||
| Q3 24 | 4.0% | 0.7% | ||
| Q2 24 | 4.5% | 0.4% | ||
| Q1 24 | 4.6% | 1.1% |
| Q4 25 | 40.73× | 1.68× | ||
| Q3 25 | 5.84× | 1.36× | ||
| Q2 25 | 1.16× | 1.66× | ||
| Q1 25 | 2.55× | 1.23× | ||
| Q4 24 | 6.84× | 1.07× | ||
| Q3 24 | 1.56× | 1.28× | ||
| Q2 24 | 1.79× | 1.12× | ||
| Q1 24 | 0.96× | 1.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
JJSF
| Food Service | $219.2M | 64% |
| Frozen Beverages | $78.7M | 23% |
| Repair And Maintenance Service | $22.5M | 7% |
| Other | $12.7M | 4% |
| Machine Sales | $10.7M | 3% |
PBH
| Womens Health | $51.8M | 18% |
| International OTC Healthcare | $47.7M | 17% |
| Gastrointestinal | $44.2M | 16% |
| Eye And Ear Care | $35.2M | 12% |
| Dermatologicals | $27.6M | 10% |
| Analgesics | $26.7M | 9% |
| Oral Care | $23.5M | 8% |
| Cough And Cold | $23.0M | 8% |
| Other Otc | $3.6M | 1% |
